This paper uses Hospital Episode Statistics, English administrative data, to investigate the growth in admitted patient health care expenditures and the implications of an ageing population. We use two samples of around 40,000 individuals who a) used inpatient health care in the financial year 2005/06 and died by 2011/12 and b) died in 2011/12 and had some hospital utilisation since 2005/06. We use a panel structure to follow individuals over seven years of this administrative data, containing estimates of inpatient health care expenditures (HCE), information regarding individuals' age, time-to-death (TTD), morbidities at the time of an admission, as well as the hospital provider, year and season of admission. We show that HCE is principally determined by proximity to death rather than age, and that proximity to death is itself a proxy for morbidity. JEL codes: H51; J11; I19.
A c c e p t e d M a n u s c r i p t successes has actually been to worsen the people's health', as improvements in health care tend to lengthen the lives of those living with illness disproportionately to the effect of such improvements on the lifespan of those living without [23] . Should population ageing occur alongside a deterioration of health at older ages, then this will exacerbate impacts on public expenditures. While subsequent academic research into these claims -notably, research in the 'compression of morbidity' and 'red herring' strands of literature -have given reason to suggest that such concerns may have been misplaced or exaggerated, concern over the impact of an ageing population on HCE has persisted. Indeed, even in 2012, the UK's then-Secretary of State for Health claimed that the fact that 'the number of people aged over 85 in this country will double in the next 20 years' was one of two factors in 'costs... rising at an unaffordable rate' [31] . He further argued that 'age is the principal determinant of health need' 1 , and that local NHS budgets should be recalibrated to be based on this, as a result [46] . This paper uses UK administrative data from Hospital Episode Statistics (HES), and deaths data from the Office for National Statistics (ONS), to consider two related research areas. The first, in line with the 'red herring' thesis advanced by Zweifel et al. [48] , is to explore the determinants of inpatient health care expenditures, with particular attention to the role played by age, time-to-death (TTD), and morbidity.
We do this in a unique way by following samples of individuals who died in England, over seven years of HES data from 2005/06 to 2011/12, and constructing a panel on individual health care expenditures and morbidity over this period. We show that TTD dominates age as a key driver of health care expenditures and morbidity characteristics dominate TTD. This finding extends the 'red herring' literature by showing that TTD is itself a 'red herring' and acts as a proxy for morbidity. This links to a second area of research by locating the modelling of health care expenditures for individuals close to death within the broader literature on prospective prediction of hospital use to inform resource allocation, particularly those based on individual level data and which incorporate information on morbidity (for example, see Iezzoni et al. [27] , van de Ven et al. [44] , Pope et al. [36] , Dixon et al. [12] ).
Literature review

Compression of morbidity
The 'compression of morbidity' strand of literature beginning with Fries [17] suggests that, '[i]n its simplest form, "the age at first appearance of symptoms of aging and chronic disease can increase more rapidly than A c c e p t e d M a n u s c r i p t life expectancy"' [19] . Fries [18] identifies three separate 'eras' of illness and well-being experienced during the 20th Century and beyond: an era of infectious disease, followed by an era of chronic disease, followed by an era described by the author as 'directly related to the process of senescence, where the aging process itself, independent of specific disease, will constitute a major burden of disease'. Senescence -the process of ageing -is characterised by the 'decline of maximal function of [all] vital organs', beginning before any chronic disease takes hold: deaths where this function declines below a level necessary to sustain life, in the absence of any disease occasioning this, may be termed 'natural deaths' [18] .
The implications for HCE of an ageing population become less clear in the light of compression of morbidity, and there are two aspects to this which deserve attention. First, as the "age at first appearance of symptoms of aging and chronic disease" increases, individuals can be said to age more healthily: the implications of this for HCE are considered below. Second, the compression of morbidity thesis takes for granted an increase in life expectancy. The implications of this for HCE can be considered at a population level for any given year of spending. Setting aside the causal process for this health ageing (again, considered below), as the average person ages more healthily, they require lower HCE at any given age. As more people live to very old age -for instance, 90 years old -each individual requires lower health spending at that age.
The overall picture for HCE is however ambiguous: a larger number of people requiring lower HCE may require greater overall costs at a population level than a smaller number of people requiring higher HCE.
Similarly, an individual, who dies at age 90 and requires lower HCE at any given age than they would had they been born into an earlier cohort, may require greater cumulative HCE over their lifespan than they would had they aged less heathily and died at the age of 70. The implications for HCE in the presence of healthy ageing and increased lifespan may differ at an individual level to a population level.
Freedman et al. [15] , in a systematic review covering research that had been conducted between 1990 and 2002 found that many measures of disability and limitations in old age had seen declines in recent years: in particular, a change of -1.55% to -0.92% per year in those reporting any disability during the late 1980s and 1990s. Romeu Gordo [39] observes a cohort-on-cohort fall in the number of individuals with high levels of disability-related functional problems in their everyday life for those born between 1924 and 1947 in the US. Cutler et al. [5] , using Medicare records from the US, present evidence of an increase in disability-free life between 1991 and 2009. The authors conclude that 'The major question raised by our results is why this has occurred. How much of this trend is a result of medical care versus other social and environmental factors?'.
Cross-country international evidence on the changing patterns of disability rates across nine OECD
A c c e p t e d M a n u s c r i p t countries is provide by Jacobzone et al. [28] . Consistent with the above literature, they report evidence of significant falls in severe disability rates. The importance of this issue for forecasting HCE depends upon how changes in mortality, changes in morbidity, and changes in disability occur and interact with each other.
If the onset of chronic conditions -those imposing large costs on health systems -can be postponed out of an individual's lifetime, then health care costs may fall as later cohorts enjoy a longer lifespan, with a reduced level of necessary treatment for chronic conditions. Dormont et al. [13] , for instance, find that improvements in morbidity profiles in France between 1992 and 2000 have caused reductions in HCE that more than offset the rise in HCE induced by an ageing population.
The morbidity and disability profile of individuals, according to this research, at any given age has improved over time, leading to health problems being experienced later in life and more closely to death. In the illustrated case ( Figures 1 and 2 2 ), individuals live up to a longer observed maximum age (indicated by the shift out of the survival curve from S 1 to S 2 in Figure 1 ), and have a higher observed level of health at all ages (indicated by the shift out of the health status curve from H 1 to H 2 in Figure 2 ). Both survival curves and health status curves have become increasingly rectangular. The effect on health care expenditure (HCE) is ambiguous, given that generally more healthy ageing -a decrease in morbidity at any given ageputs downward pressure on HCE, while an increase in life expectancy, ceteris paribus, puts upward pressure on HCE. The actual relationship between health care costs and changes in morbidity and mortality profiles at every given age depends upon the changing shape of these two curves, and also the extent to which the changes in each are due to or caused by the healthcare that creates these HCE. The use of age per se in predicting future health care costs should be approached with caution, as a result. M a n u s c r i p t The 'red herring' strand of literature further gives empirical reason to suggest that claims of steeply-rising future HCE due to population ageing 3 may have been exaggerated, potentially owing to morbidity being concentrated in later years of life. Zweifel et al. [48] , using Swiss sickness fund data, find that no effect of age on health care expenditures existed after controlling for TTD, i.e. the time from any given point of observation to death for an individual. Owing to the number of individuals with zero HCE, a two-step model (with a probit first stage and OLS second stage) was employed, with only deceased patients included in the model. Such work was criticised on the grounds of potential endogeneity, with time-to-death affected by both present, previous (and, due to the nature of how TTD must be measured) future HCE. In a subsequent paper, Zweifel et al. [49] seek to test for such problems, finding that while TTD is endogenous, their results were 'fairly robust' to the error this induces. Werblow et al. [45] find that age is a small (but statistically significant) determinant of HCE after controlling for TTD for patients using long-term care (LTC), such as those in care homes, and is not associated with HCE for non-LTC patients. More complicated methods, such as those employing generalised linear models, have since been used, for example by Werblow et al. [45] , in order to deal with the non-normal properties (such as positive skewness) exhibited in the distribution of HCE. These papers have corroborated results obtained using probit and OLS two-step models. Felder et al. [14] , in a recent paper in this series, first predict individuals' survival based on observed HCE and socioeconomic characteristics (in early waves), before using predicted values based on this as an instrument for TTD in explaining HCE in later waves. The authors find that, while TTD cannot be deemed exogenous, any effect of age on HCE becomes insignificant when TTD (or instrumented TTD) is included in the model. Furthermore, results regarding the relative importance of TTD compared to age have also been corroborated in a disease-specific study carried out by Wong et al. [47] .
While use has been made of morbidity markers in models of long-term care expenditures (LTCE) (see de Meijer et al. [8] ), such use has not been made in models explicitly investigating the link between HCE and population ageing. One possibility is that TTD is itself a red herring, in that it is simply a proxy for morbidity, unobserved in existing HCE models in the red herring strand of literature. Such a theory has been provisionally borne out empirically in literature related to economic evaluation of healthcare, with Gheorghe et al. [20] finding that quality of life (as measured by SF-6D scores) declines with proximity to death, and also by biological and medical literature. Indeed, Dalgaard and Strulik [6] , proposing an alternative life cycle A c c e p t e d M a n u s c r i p t model of ageing, note that previous work in the 'red herring' strand of literature is consistent with biological and medical research (see, inter alia Mitnitski et al. [32, 33, 34] , Rockwood and Mitnitski [37, 38] ), showing that conceptions of ageing focusing on time-from-birth (such as that inherent in Grossman [22] ) are erroneous.
This model conceptualises the human body as a system which has substantial inbuilt redundancy (that is, an ability to function at a level well over and above that required to sustain life) in youth, but redundancy which declines as 'deficits' (a decline in function of individual parts of the body) are accumulated. Ageing depends not upon a 'biological clock', but is a process of increasing frailty which is the outcome of investments in health, available health technology, the lived environment, and a physiological 'force of aging' parameter.
According to such a model, health is predicted to decline at an increasing rate when the individual's health status is lower. The authors note that existing research in the 'red herring' strand of literature, in line with this, 'suggests that health status (e.g., frailty), and not the year on the birth certificate, is what matters to health investments'. The latent assumption here is that a TTD variable proxies for this health status, which declines as individuals become more morbid as they approach death, and with ever-increasing levels of health investment to (partly) offset this decline in health status and postpone death.
This seems intuitively plausible: in the years before death, it is likely that morbidity will increase, leading to more treatment, and that comorbidities complicating the treatment of the disease bringing about the hospital episode will also increase. Shwartz et al. [41] , in work predating the original red herring hypothesis, note that the inclusion of variables for comorbidities increase substantially the explanatory power of models.
It seems likely that, as Dalgaard and Strulik [6] suggest, variables incorporating 'time-to-death' in more recent models of HCE are picking up, in large part, these comorbidities, which are not included in existing HCE models in the red herring literature. Indeed, de Meijer et al. [8] conclude that time-to-death 'largely approximates disability' in models of LTCE. Dixon et al. [12] , in proposing individual-level formulae for resource allocation in the UK's National Health Service (often termed 'Person-Based Resource Allocation', or PBRA) include individual level morbidity markers, finding that these have a 'powerful effect... in predicting individual level expenditure'.
The process generating HCE is clearly not a simple function of those explanatory variables used in existing 'red herring' research: the actual data-generating process behind these health care expenditures is unlikely to be characterised accurately by a simple use of age, historical time and time-to-death. In addition to the aforementioned problems surrounding TTD and age as a proxy for morbidity, as Breyer et al. [3] note, many existing models are likely to be characterised with substantial endogeneity problems, which lead to potential bias in the estimation of the change in HCE as an individual ages or approaches death. The authors control A c c e p t e d M a n u s c r i p t for potential endogeneity introduced by differential treatment based on a physician's view of the patient's expected health benefits from treatment, proxied by actuarial tables of life expectancy conditional on age. If physicians expect individuals to respond differently to treatment, this may cause those who are more likely to respond to treatment to be treated more intensely than those who are not, thus increasing expected HCE for individuals who are younger, further-from-death or with fewer comorbidities because of physician selection. Gray [40] ) being the overestimation of expected costs for a given future year when TTD is an omitted variable. This is due to the collinearity between TTD and age for a given individual: an individual who gets one year closer to death also gets one year older, and so the impact of TTD is picked up by age in such models. The inclusion of morbidity markers in addition to, or replacing, TTD would allow greater precision of future estimates where reliable estimates of morbidity prevalence, and the cost of treatments, conditional on age and TTD were known. Certainly, if the compression of morbidity hypothesis holds, and individuals are able to postpone the onset of chronic diseases -with associated higher HCE -to a time period closer to their death, or even indefinitely, explicitly considering morbidity rather than proxying this by age or TTD becomes ever more important.
We build upon the compression of morbidity and red herring strands of existing literature, seeking to further examine the relationship between ageing, time-to-death and health care expenditures. The original A c c e p t e d M a n u s c r i p t red herring hypothesis is that, once time-to-death is included in models of HCE, age per se does not explain changes in HCE. While models intended for resource allocation [12] Information regarding inpatient spells is used to associate reference costs to each spell. Reference costs are based on each NHS provider's estimates of their own costs for each patient spell, categorised by Healthcare
Resource Group (HRG, the NHS's system of grouping clinically-similar events with comparable resource use.). These reference costs are derived from accounting costs for each HRG, submitted by each organisation providing secondary care in England [11] . The NHS Costing Manual provides guidance to all providers to support the calculation of reference costs and to enforce more uniform standards for costing methodologies.
We use the estimate provided by the hospital providing treatment as our estimated cost for the patient's episode. The DH's Reference Cost data is submitted on a full absorption basis -that is, taking account of all direct and indirect costs relating to the activities in question, as well as a proportion of an estimate of all overhead costs relating to the overall running of the provider. Further, to account for the fact that costs will vary even within HRGs, hospitals are required to provide per diem costs for longer admissions that exceed a given 'trim point', which differs by each HRG. This trim point is defined as the upper quartile of length of stay, plus 1.5 times the inter-quartile range for length of stay for that HRG [11] . Moreover, we augment We adopt a strategy that employs two complementary sampling procedures, each incorporating approx- not to become burdensome, and the age cut-off was selected to ensure sufficient deaths were observed in the data to make meaningful inference. We follow all sampled individuals across all quarters until their death to observe their subsequent inpatient health care use and associated morbidity characteristics.
We collapse all inpatient episodes for each individual from HES for a given quarter into a single observation in our data. This observation contains the sum of all hospital costs incurred in all episodes finishing in that quarter, as well as diagnostic information contained in the ICD-10 codes for those episodes in that quarter.
In principle, the ICD-10 classification allows for up to 14,400 different diagnoses. To make these more manageable for analysis, however, we collapse this information using the US Agency for Healthcare Research and Quality's Clinical Classifications Software (CCS) method to convert ICD-10 codes to CCS codes [43] .
This reduces the number of different groupings to a more manageable 260 mutually-exclusive, and clinically meaningful, categories 7 . Where individuals do not have any episodes in a given quarter, we separately adopt two distinct methods in order to deal with such cases. In one approach, they are recorded as having zero hospital costs, and as having zero observed morbidities arising from diagnostic information. In the absence of additional information on the gravity of any residual health problem, this assumes that such health issues are insignificant relative to those leading to a hospitalisation. In a second approach, we recognise that the recording of zero morbidities might be unrealistic for patients observed to have hospitalisations in recent periods and for whom there is likely to exist an underlying, albeit less grave, health problem. Consequently, we model these cases in our second approach under the assumption that episodes for which no information is available represent non-informative, missing data.
While we include a sum of all hospital costs for episodes ending in the quarter in question, we include only a maximum of three diagnoses for each individual, for a maximum of five episodes ending in that quarter.
Using the merged mortality data, we are able to add a variable for the individual's time-to-death, measured 7 A full list of these CCS groupings is provided in Appendix Appendix A A c c e p t e d M a n u s c r i p t As is usual, the distribution of HCE is positively skewed, with this skewness reduced somewhat when we take a logarithmic transformation. 10 As would be expected due to their longer lifespan, on average, the average age of women in the sample is somewhat higher than that for men. Similarly, women are observed for, on average, slightly more waves. HCE, with missing waves treated as zero-(log)-cost observations, is on average higher when sampling from the first financial year of data than when sampling from those who died As the proportion of the full population who are decedents increases with age, the näive observed relationship between age and expenditure displays an increasing trend. Note, however, that average expenditures for both decedents and survivors display a flatter profile than that depicted for the full population suggesting a less important role for age. Indeed, expenditure on decedents generally decrease, with this decrease particularly pronounced for women. Expenditure on survivors generally increase, but with a shallower gradient than observed for the full population, and at a lower average cost.
When we focus on decedents, and consider average HCE by proximity to death, we observe a large increase in costs in terminal quarters -particularly in the year immediately before death. Figure A The relationship between HCE and TTD in levels is nonlinear. Figure 5 shows that the relationship is approximately linear on the logarithmic scale and in the modelling that follows logarithms of both HCE and TTD are used throughout. 
Econometric model
We follow the general strand of the red herring literature and specify a baseline model of HCE, including only age as an explanatory variable.
where τ it is a vector of control variables (year and season of admission, and hospital provider dummies) µ i is an individual-specific unobserved effect and ε it is an idiosyncratic error term. Although this model is not estimated in existing papers, it is claimed that such a model would not adequately explain HCE. TTD is claimed to be an omitted variable in these models, giving rise to models such as:
A c c e p t e d M a n u s c r i p t
We argue that individual morbidity is an omitted variable in this type of model, where TTD functions as a proxy for such morbidity 13 . Accordingly, we augment the model as follows:
where CCS n represents a recorded morbidity of CCS type n (n = 1...260). We exploit the available data in HES to include detailed information about a patient's morbidities at the time of their hospital stay. We estimate each of these models with random effects, representing unobserved heterogeneity.
Modelling HCE as a function of TTD suffers from potential problems of endogeneity. Existing literature suggests that conditional on other covariates, being further from death -i.e. having a high TTD -in time period t is likely to lead to lower levels of HCE in t. Higher levels of HCE it , however, are likely to lead to high levels of T T D it : if the hospital activity that generates health care expenditures is effective in improving health then the individual is likely to enjoy a longer remaining lifespan as a result. We therefore posit that actual TTD at time period t has been determined in part by HCE in that time period as well as other time periods. Consequently, if endogeneity does pose problems in this analysis, the coefficient estimate on TTD (when treated as exogenous) is likely to be an underestimate of the true 'effect' of TTD.
Other models in the red herring strand of literature model HCE, using TTD and age as explanatory variables, but highlighting this endogeneity problem. Various attempts are made to purge TTD of its endogeneity in HCE [49, 45, 14] . A c c e p t e d M a n u s c r i p t
Results
All versions of our different sampling and modelling strategies lead to qualitatively similar results. In short, a weak (and often statistically insignificant) relationship is observed when costs are modelled as a function of age alone. Confirming the overall red herring results, a strongly significant relationship is observed between TTD and HCE, when TTD is added as an explanatory variable. This is in line with our descriptive diagrams (Figures 3 & 4) , demonstrating that the naïvely-estimated relationship between age and HCE is muted when conditioning on TTD. When morbidities are included as explanatory variables, the relationship between TTD and HCE is reduced (in all cases, the coefficient is reduced by approximately two-thirds). When, where possible, instrumenting TTD, the relationship between TTD and age becomes larger, with the addition of morbidities again reducing the size of the TTD cofficient. 15 Table 5 presents the results of various specification of a random effects panel data model of log(HCE) on age, log(TTD) and morbidity characteristics for the sub-sample of decedents, when a sample is drawn from those who died in 2011/12. The first column of results (model 1) shows a weak and generally nonsignificant relationship between age and inpatient costs. These results represent, as far as we are aware, the first reported results in the red herring strand of literature of whether hospital costs increase with age in the aggregate, even before control is made for other factors such as TTD and morbidities. Existing research broadly states that this is the case, but refer merely to population-level descriptive statistics. In a random effects model (2) including TTD and age, we observe a highly significant relationship with TTD. This result is in line with those in the red herring strand of existing research. As an individual gets 1% closer to death, HCE increases by between 0.34% and 0.42% for men (between 0.28% and 0.34% for women), depending on the modelling strategy adopted 16 .
A c c e p t e d M a n u s c r i p t Conditioning on morbidity markers, we find a reduced role for TTD in explaining HCE, using both sampling strategies. Our estimate of the TTD elasticity of HCE falls by approximately two-thirds in almost all (non-IV) cases when we condition on the individual's observed morbidity in the current time period (i.e., when we move from model 2 to model 3). In all models, in excess of 90% of the estimated coefficients for the morbidity indicators are significant at the 1% level, yielding a p-value of 0.0000. We interpret this as indicating that TTD does indeed serve as a proxy for unobserved morbidity. The estimated coefficients for age when morbidity markers are included see similar falls. This is illustrated in Figure 6 which shows the difference in log (HCE) from the quarter of death to preceding quarters for an individual who dies at age 75 for the alternative specifications of the model 17 . The combined relationship of time-to-death and age is severely muted when we condition on current morbidity markers as seen by the lines representing RE AGE TTD MORBS and RE AGE TTD.
We anticipate hospital costs to rise as individuals approach death, and as such expect a negative relationship between TTD and HCE. For the sampling strategy where this is possible -sampling from the first calendar year -we instrument for TTD in order to deal with the potential endogeneity of TTD in HCE, which would mean that a naïve estimate of the 'effect' of TTD on HCE was likely to be biased towards zero (i.e. that naïve estimates would be expected to be less negative). In a further pair of models, we instrument TTD with LSOA-level YPLL measures, our small-area measure of premature mortality.
When we instrument using YPLL measures -model (4) -the estimated coefficient of log(TTD) rises (in absolute terms) in all cases. While we confirm the findings of Zweifel et al. [49] that 'the proximity of death rather than age [being] a main determinant of HCE is fairly robust to endogeneity error,' our results also suggest that failing to account for the endogeneity of TTD in these models may lead to a large underestimate of the true 'effect' of TTD in models that do not include morbidity markers 18 . This is also illustrated in Figure 6 , which shows the large divergence in estimated costs for these two models for an individual who dies at the age of 75. As expected, first-stage regressions show a negative and significant relationship between YPLL and TTD and an F-test of these instruments suggests their relevance as a predictor of TTD according to the commonly used Stock-Yogo 'rule of thumb' of an F-statistic of 10 in all cases.
A c c e p t e d M a n u s c r i p t level TTD is unknown and hence to forecast future expenditure growth assumptions about the proportions of decedents and survivors together with projections of populations within age groups is required. By extending the modelling of HCE to include morbidity characteristics we show that the impact of TTD is diminished indicating that it acts as a proxy for underlying health status. This is important to allow the planning of future resource requirements and in developing appropriate models for budgets to be allocated equitably across providers of care in response to population health care need. Our results are robust to problems of endogeneity that exist between HCE and TTD.
Our results strengthen the need to include measures of morbidity in models of HCE. Merely including TTD is insufficient in predicting future HCE. To accurately forecast future expenditure needs, information on changes to profiles of morbidity are required. The existence of a compression of morbidity, along with a A c c e p t e d M a n u s c r i p t tendency for increased life expectancy, suggests competing and opposing pressures on HCE. While increases in life expectancy suggests that a greater number of individuals will be alive at any given age, with associated upward pressure on HCE, a compression of morbidity will tend to, on average, provide downward pressure on HCE for any given individual at any given age.
This work has focused on determinants of the demand for inpatient health care services at an individual level via age, time-to-death and morbidity characteristics. Clearly there is also a substantial role for supplyside impacts on expenditure growth notably through technological advances in health care interventions and the way in which health care services are organized and delivered. We do not address these issues here, Sexually transmitted infections (not HIV or hepatitis) 10
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